Skip to content
Application 022315
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OZURDEX | DEXAMETHASONE | IMPLANT;INTRAVITREAL | 0.7MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |
| 0023-3348 | OZURDEX | dexamethasone | Allergan, Inc. | NDA | Current |